OCGN Q4 2016 Earnings — Ocugen, Inc. Revenue & Financial Results | Market Cap Arena

OCGNOcugen, Inc.

$710M

Q4 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$8M

Net Income

$9M

EPS (Diluted)

$31.06

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$468,000

Balance Sheet

Total Assets

$36M

Total Liabilities

$23M

Stockholders' Equity

$14M

Cash & Equivalents

$32M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$8M	-$8M	+4.9%
Net Income	$9M	-$8M	+208.6%